Mimedx (MDXG) Deferred Taxes (2016 - 2026)
Mimedx recorded quarterly Deferred Taxes of $4.5 million in Q1 2026, up 320.92% quarter-over-quarter from -$2.1 million in Q4 2025, and up 829.63% year-over-year from $487398.4 in Q1 2025.
Mimedx's Deferred Taxes history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 829.63% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at -$3.6 million (up 67.84% YoY), while the FY2025 annual figure was -$8.7 million, up 30.16% from the prior year.
- Deferred Taxes came in at $4.5 million for Q1 2026 at Mimedx, up from -$2.1 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $37.8 million in Q4 2023 to a low of -$5.8 million in Q3 2025.
- A 4-year average of $2.1 million and a median of -$2.0 million in 2024 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes sank 106.16% in 2024 and soared 829.63% in 2026, its largest moves.
- Mimedx's Deferred Taxes stood at $37.8 million in 2023, then tumbled by 106.16% to -$2.3 million in 2024, then gained by 11.97% to -$2.1 million in 2025, then surged by 320.92% to $4.5 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $4.5 million, -$2.1 million, and -$5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -5.75 Mn |
| Jun 30, 2025 | -287,000.00 |
| Mar 31, 2025 | -621,000.00 |
| Dec 31, 2024 | -2.33 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -5.31 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 37.80 Mn |
| Dec 31, 2018 | 23.98 Mn |
| Sep 30, 2018 | 5.84 Mn |
| Jun 30, 2018 | -3.01 Mn |
| Mar 31, 2018 | -1.27 Mn |
| Dec 31, 2017 | -18.11 Mn |
| Sep 30, 2017 | -7.53 Mn |
| Jun 30, 2017 | -614,000.00 |
| Mar 31, 2017 | -416,000.00 |
| Dec 31, 2016 | -5.54 Mn |
| Sep 30, 2016 | -93,000.00 |
| Jun 30, 2016 | -356,000.00 |